Sunday, October 18, 2026 from 4:00 p.m. to 5:30 p.m. MDT at Salt Palace Convention Center - Ballroom G
Available for 1.50 hours of CPE creditActivity Number: 0217-0000-26-011-L01-PActivity Type: An Application-Based ActivityWhile SGLT2 inhibitors have garnered significant attention in nephrology, a range of other emerging therapies for conditions like anemia, IgA nephropathy, and more are either already approved or expected to be approved in the near future. As these new treatments reshape the landscape, healthcare providers must adapt to the changing therapeutic options and navigate the complexities of their implementation, from inpatient settings to ambulatory care. Key challenges include ensuring effective integration of these innovations in disease state management into clinical practice along with implementation of assessing kidney function with adjusting drug dosages across various stages of kidney disease.
Learning Objectives1. Describe the mechanisms of action and clinical benefits of emerging nephrology therapies, including treatments for anemia, IgA nephropathy, and other kidney-related conditions.
2. Analyze the key considerations for integrating new therapies into clinical practice for management of anemia, IgA nephropathy, and other kidney-related conditions, including selection based on patient specific factors and laboratory values, ongoing monitoring requirements, and management of potential adverse effects.
3. Examine the evolving role of pharmacists in implementing new kidney disease treatments while ensuring patient safety and optimizing therapeutic outcomes.
4. Discuss the challenges associated with assessing kidney function and adjusting drug dosages across various stages of kidney disease.
 | | Moderator: | Christine A. Schumacher, Pharm.D., FCCP, BCACP, BCCP, BCPS | | Professor, Pharmacy Practice
Director, PGY2 Ambulatory Care Residency Program
Midwestern University College of Pharmacy, Downers Grove Campus
Clinical Pharmacist, Northwestern Medicine | | View Biography |
|
Kidney Disease Unfiltered: Innovations, Challenges, and Future Directions4:00 p.m. to 4:45 p.m. | | Speaker: | Katie E. Cardone, Pharm.D., FCCP, FNKF, FASN | |
Professor and Chair
Dept of Pharmacy Practice
Albany College of Pharmacy and Health Sciences
Albany, New York | | View Biography |
|
|
Empowering Kidney Health: Innovative Approaches to Comprehensive Disease Management4:45 p.m. to 5:30 p.m. | | Speaker: | Tracy Anderson-Haag, Pharm.D., BCPS, BCTXP | | Clinical Pharmacy Specialist-Transplantation
Residency Program Director, PGY-2 Solid Organ Transplant
Hennepin Healthcare
Minneapolis, MN
and
Adjunct Associate Professor
University of Minnesota, College of Pharmacy
Minneapolis, MN
| | View Biography |
|
|